Surgery Partners Names Angela Justice Chief Human Resource Officer
23 Februar 2018 - 01:00PM
Newly created position highlights the
importance of talent development to the Company’s long-term growth
strategy
Surgery Partners, Inc. (NASDAQ:SGRY) (the “Company”), a leading
healthcare services company, today announced that it has appointed
Angela Justice, PhD as the Company’s Chief Human Resources Officer.
The role was created in line with Surgery Partners’ long-term
growth strategy and commitment to employee development. Dr. Justice
will lead the Human Resources department and play a critical role
in advancing the Company’s growth objectives and developing its
human capital.
Dr. Justice has more than 15 years of experience in healthcare
and human resources leadership. She most recently served as Chief
Learning Officer at Biogen, Inc., an American multinational
biotechnology company based in Cambridge, Massachusetts. She
assumed a variety of responsibilities in her role including
creating and leading a centralized learning organization supporting
14,000 people across all departments and geographies, spearheading
the implementation of a learning technology system that was
considered one of Biogen’s largest and most successful IT projects,
and making learning a competitive force with measurable business
impact. She also served as senior director of Global Medical
Affairs for Biogen, and was an active member of the Human Resources
Leadership Team.
Wayne DeVeydt, Chief Executive Officer, stated, “Angela has a
strong human resources background and deep expertise in the
healthcare industry, medical affairs and project management. She is
a highly accomplished and innovative leader with proven strategies
for building top teams, mitigating organizational risks and
creating meaningful cultural change for companies and their
employees. We are confident that Angela will be instrumental in
helping advance our long-term goals, which include strengthening
our talent pool and creating additional opportunities for employee
development.”
Dr. Justice said, “I am excited to have the opportunity to
collaborate with Wayne and the rest of the Surgery Partners team in
serving and developing the people who make this business possible.
I am looking forward to contributing to the next level of growth
for this esteemed organization and leveraging this important work
to create value for all stakeholders that touch Surgery
Partners.”
Dr. Justice has held leadership roles at EMD Serono, the
National MS Society, and was a management consultant at McKinsey
& Company. She received her PhD in Biopsychology from the
University of Chicago, where she was also an adjunct faculty
member.
She will start in her new role at Surgery Partners on March 12,
2018 and will report directly to Mr. DeVeydt.
About Surgery Partners, Inc.Headquartered in
Brentwood, Tennessee, Surgery Partners is a leading healthcare
services company with a differentiated outpatient delivery model
focused on providing high quality, cost effective solutions for
surgical and related ancillary care in support of both patients and
physicians. Founded in 2004, Surgery Partners is one of the largest
and fastest growing surgical services businesses in the country,
with more than 180 locations in 32 states, including ambulatory
surgery centers, surgical hospitals, a diagnostic laboratory,
multi-specialty physician practices and urgent care facilities. For
additional information, visit www.surgerypartners.com.
Forward-Looking Statements
This press release contains forward-looking statements,
including those regarding growth and our anticipated operating
results for 2017 and other similar statements. These statements can
be identified by the use of words such as “believes,”
“anticipates,” “expects,” “intends,” “plans,” “continues,”
“estimates,” “predicts,” “projects,” “forecasts,” and similar
expressions. All forward looking statements are based on
current expectations and beliefs as of the date of this release and
are subject to risks, uncertainties and assumptions that could
cause actual results to differ materially from those discussed in,
or implied by, the forward-looking statements, including but not
limited to, the risks identified and discussed from time to time in
the Company’s reports filed with the SEC, including the Company’s
Quarterly Reports on Form 10-Q for the quarterly periods ended
September 30, 2017 and June 30, 2017, filed on
November 9, 2017 and August 9, 2017, respectively. Except as
required by law, the Company undertakes no obligation to revise or
update publicly any forward-looking statements to reflect events or
circumstances after the date of this report, or to reflect the
occurrence of unanticipated events or circumstances. In
addition, the financial information for the fiscal year ended
December 31, 2017 is unaudited and subject to quarter-end and
year-end adjustments in connection with the completion of our
customary financial closing procedures. Such changes could be
material.
Investors:
FTI Consulting(615) 234-8940IR@surgerypartners.com
Media:
FTI Consulting(212)
850-5681surgerypartners@fticonsulting.com
Surgery Partners (NASDAQ:SGRY)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Surgery Partners (NASDAQ:SGRY)
Historical Stock Chart
Von Mär 2023 bis Mär 2024